N🟁N

CryoPort to Present at the 3rd Annual LD MICRO Growth Conference on December 9

  //house-home.news-articles.net/content/2010/12/0 .. al-ld-micro-growth-conference-on-december-9.html
  Published in House and Home on Wednesday, December 1st 2010 at 5:05 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

SAN DIEGO--([ BUSINESS WIRE ])--CryoPort, Inc. (OTCBB: CYRX) today announced that Larry Stambaugh, Chairman and Chief Executive Officer, will be presenting at the 3^rd Annual LD MICRO Growth Conference in Los Angeles on Thursday, December 9, 2010 at 8:30 a.m. Pacific. The conference is being held at the Luxe Sunset Boulevard Hotel.

"We are very pleased that a California based company with fantastic growth potential chose to present at our event. We are excited to learn more about their unique story."

President of LD MICRO, Chris Lahiji stated, aWe are very pleased that a California based company with fantastic growth potential chose to present at our event. We are excited to learn more about their unique story.a

About LD MICRO

LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor.

For more information on the list of presenting companies or to register for the event, please visit [ http://www.ldmicro.com ] or call (408) 457-1042.

About CryoPort, Inc.

CryoPort ([ www.cryoport.com ]) has developed a leading edge, proprietary, technology-driven transport and packaging system focused on providing a solution that replaces dry ice for the frozen shipping market in the growing global life science industry. The products developed by CryoPort have a 10+ day holding time, are using agreena materials and are essential components of the infrastructure required for the testing, research and end-user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex global logistical environment. For more information, visit [ www.cryoport.com ].